Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 876431, 7 pages
http://dx.doi.org/10.1155/2014/876431
Research Article

Effect of Jingqian Zhitong Fang on Serum Sex Hormone Levels in Women with Primary Dysmenorrhea

1Tianjin State Key Laboratory of Modern Chinese Medicine, School of Traditional Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, No. 312 Anshan West Road, Tianjin 300193, China
2Obstetrics and Gynecology Hospital in Tianjin, Tianjin 300193, China

Received 23 December 2013; Revised 8 March 2014; Accepted 25 March 2014; Published 16 April 2014

Academic Editor: Ling Yang

Copyright © 2014 Na Dai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. French, “Dysmenorrhea,” American Family Physician, vol. 71, no. 2, pp. 285–291, 2005. View at Google Scholar · View at Scopus
  2. A. R. Davis and C. L. Westhoff, “Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives,” Journal of Pediatric and Adolescent Gynecology, vol. 14, no. 1, pp. 3–8, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. The World of Traditional Medicine, Gynecology, Sciences Press, Beijing, China, 1999.
  4. M. Y. Dawood, “Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea,” The American Journal of Medicine, vol. 84, no. 5, pp. 23–29, 1988. View at Google Scholar
  5. V. R. Pickles, W. J. Hall, F. A. Best, and G. N. Smith, “Prostaglandins in endometrinm and menstrual fluid form normal and dysmenorrhoeic subjects,” The Journal of Obstetrics and Gynaecology, vol. 72, pp. 185–192, 1965. View at Google Scholar · View at Scopus
  6. A. M. Powell, W. Y. Chan, P. Alvin, and I. F. Litt, “Menstrual-PGF(2α), PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea,” Prostaglandins, vol. 29, no. 2, pp. 273–289, 1985. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-L. Kang, X.-X. Wang, M.-L. Nie, and X.-H. Huang, “Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis,” Gynecologic and Obstetric Investigation, vol. 69, no. 2, pp. 73–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Kaaks, F. Berrino, T. Key et al., “Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC),” Journal of the National Cancer Institute, vol. 97, no. 10, pp. 755–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Pfeiffer, E. Graf, S. Gerstner, and M. Metzler, “Stimulation of estradiol glucuronidation: a protective mechanism against estradiol-mediated carcinogenesis?” Molecular Nutrition and Food Research, vol. 50, no. 4-5, pp. 385–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Hong, “The clinical observation of female pelvic blood flowing diagram to blood stasis dysmenorrhea and preliminary study of the application,” Obstetrics and Gynecology, vol. 19, no. 4, article 203, 1984. View at Google Scholar
  11. R. Peng-fei and D. Yi, “Study progress on pharmacodynamics of DangGui and its active ingredients,” Western Journal of Traditional Chinese Medicine, vol. 25, no. 9, pp. 125–128, 2012. View at Google Scholar
  12. G. Yujun and M. Aolei, “Analysis of the pharmacological effects of motherwort,” Seek Medical and Ask the Medicine, vol. 10, no. 6, article 791, 2012. View at Google Scholar
  13. G. Jiansheng and G. Qianyao, “Advances in modern medicine pharmacology Chuanxiong,” in Proceedings of the 5th National Symposium on Clinical Pharmacy, pp. 239–243, 2012.
  14. X. Xiuiqiong, Z. Ke, and Y. Rongli, “Progress of Chuanxiong volatile oil,” Lishizhen Medicine and Materia Medica Research, vol. 18, no. 6, pp. 1508–1510, 2007. View at Google Scholar
  15. J. Lan-Xin, H. Hao, and L. Chang-Zhi, “Review in research of radix paeoniae rubra,” Drug Evaluation Research, vol. 33, no. 6, pp. 233–236, 2010. View at Google Scholar
  16. L. Fang, X. Zhu, and C. Zhu, “The study of Mechanism of the three analgesia prescriptions previous to menstrual cycle to treat primary dysmenorrhrea,” Chinese Herbal Medicine, vol. 41, no. 4, pp. 615–617, 2010. View at Google Scholar
  17. Y. Jin and Y. Hong, “Advancements in the chemical constituents and pharmacological effects of chuanxiong,” Pharmacy and Clinics of Chinese Materia Medica, vol. 4, no. 3, pp. 44–48, 2013. View at Google Scholar
  18. K. Fang, X. Zhu, and J. Yin, “The study of mechanism of the three analgesia prescriptions previous to menstrual cycle to treat experimental rat model of dysmenorrhrea,” Tianjin Traditional Chinese Medicine, vol. 27, no. 1, pp. 46–49, 2010. View at Google Scholar
  19. D. Huang, “The observation and summarization of TCM cycle therapy to treat primary dysmenorrhrea with 285 patients,” Chinese Medicine Research, no. 6, pp. 17–18, 1995. View at Google Scholar
  20. T. Yamamoto, T. Noguchi, T. Tamura, J. Kitawaki, and H. Okada, “Evidence for estrogen synthesis in adenomyotic tissues,” American Journal of Obstetrics and Gynecology, vol. 169, no. 3, pp. 734–738, 1993. View at Google Scholar · View at Scopus
  21. G. Liu, J. Li, and Y. Liu, “The effect of yitong xiao to the levels of TXB26-Keto-PGF1α and β-EP in rat with endometriosis,” Shandong Medication, vol. 50, no. 44, pp. 61–62, 2010. View at Google Scholar